Company fact sheet
Ticker
MRK
Name
We are called MSD everywhere outside of the U.S. and Canada. In the U.S. and Canada, we are known as Merck & Co., Inc., Rahway, N.J., USA. The company is listed on the New York Stock Exchange under the symbol “MRK.”
Description
At MSD, known as Merck & Co., Inc., Rahway, NJ, USA in the United States and Canada, we are unified around our purpose: We use the power of leading-edge science to save and improve lives around the world. For more than 130 years, we have brought hope to humanity through the development of important medicines and vaccines. We aspire to be the premier research-intensive biopharmaceutical company in the world – and today, we are at the forefront of research to deliver innovative health solutions that advance the prevention and treatment of diseases in people and animals. We foster a diverse and inclusive global workforce and operate responsibly every day to enable a safe, sustainable and healthy future for all people and communities.
Employees
Approximately 72,000 (as of Dec. 31, 2023)
Headquarters
Rahway, New Jersey, USA
Businesses
Pharmaceuticals
Vaccines
Animal Health
2023 Revenue
$60.1 billion
2023 Revenues
(by geographic area, including pharmaceutical and animal health revenue)
| $28.5 B | United States |
| $13.3 B | Europe, Middle East and Africa |
| $ 6.8 B | China |
| $ 3.2 B | Japan |
| $ 3.2 B | Asia Pacific (other than Japan and China) |
| $ 3.1 B | Latin America |
| $ 2.1 B | Other |
2023 R&D expenses
$30.5 billion
Products
MSD is a global health care company that delivers innovative health solutions through its prescription medicines, vaccines, biologic therapies, and animal health products.
Pipeline
MSD has a robust pipeline, with a wide range of product candidates across each phase of development.
Senior leadership
Robert M. Davis, chairman and chief executive officer
